-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on vTv Therapeutics, Raises Price Target to $47

Benzinga·12/19/2025 15:20:57
語音播報
HC Wainwright & Co. analyst Emily Bodnar maintains vTv Therapeutics (NASDAQ:VTVT) with a Buy and raises the price target from $36 to $47.